Baker Avenue Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Baker Avenue Asset Management's BMY Position: Q2 2026 in Review

Baker Avenue Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q2 2026, selling an estimated $307K and leaving 17,475 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #299.

Baker Avenue Asset Management first reported a position in BMY in Q3 2014 and has held it in 18 quarters since. The position peaked at $1.38M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Baker Avenue Asset Management held 17,475 shares of Bristol-Myers Squibb worth $1.01M as of Q2 2026.
• Baker Avenue Asset Management sold 5,338 Bristol-Myers Squibb shares in Q2 2026, an estimated $307K.
• Bristol-Myers Squibb made up 0.02% of Baker Avenue Asset Management's portfolio in Q2 2026, its #299 holding.
• Baker Avenue Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 18 quarters since.
• Baker Avenue Asset Management's Bristol-Myers Squibb position peaked at $1.38M in Q1 2026.
• 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.